Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02416154 · ClinicalTrials.gov registry record
Expression of IFN-epsilon in the Female Reproductive Tract
A clinical trial, sponsored by University of Pittsburgh.
- Completed
- Registry status
- 32
- Enrollment target
NCT02416154 is a clinical trial that has completed, run by University of Pittsburgh. The registered enrollment target is 32 participants.
The verdict
NCT02416154 has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- 32 participants
- Enrollment target
Study Summary
The proposed study aims to determine the expression of Interferon-ε (IFNε) in the female genital tract, which has never been mapped before in humans. High expression in other mammalian female reproductive tract (FRT) has been suggested to be important in anti-sexually transmitted infection (STI)/HIV immunity and its expression decreases with progestogen treatment. Future studies are planned to understand if hormonal contraceptives affect the presence of interferon in the healthy female genital tract, potentially changing the risk of for STI and HIV.
Interventions
- PROCEDURE Reproductive tract and blood sampling
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2015-07 |
| Est. Completion | 2020-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02416154
The ClinicalTrials.gov registry entry for NCT02416154 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Reproductive tract and blood sampling is the first listed.
NCT02416154 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02416154 about?
NCT02416154 is a clinical study titled "Expression of IFN-epsilon in the Female Reproductive Tract". The proposed study aims to determine the expression of Interferon-ε (IFNε) in the female genital tract, which has never been mapped before in humans. High expression in other mammalian female reproductive tract (FRT) has been suggested to be important in anti-sexually transmitted infection (STI)/HIV...
What is the current status of trial NCT02416154?
This trial is currently completed. The enrollment target is 32 participants. The study started on 2015-07. Estimated completion is 2020-05.
What interventions are being tested in trial NCT02416154?
The interventions under investigation include: Reproductive tract and blood sampling (PROCEDURE).
Who is sponsoring clinical trial NCT02416154?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.